About HDI's Products
Events
Distributorship
News
Research Studies
Employment
Search
Contact Us
Legal/Section 16
Home
   

      

CVProfilor® CardioVascular Profiling System

The CVProfilor® DO-2020: An easy-to-use, non-invasive System designed to provide physicians in the U.S. with a means for assessing a patient’s vascular health.

The CVProfilor® utilizes HDI’s patented, proprietary and validated blood pressure waveform technology. The System is non-invasive, user-friendly, designed for use in U.S. physician offices and clinics, and involves no specific medical risk to the patient. 

The System’s display screen and printer-generated CardioVascular Profile Report provide an independent assessment of the patient’s arterial elasticity or flexibility of both large and small arteries (referred to as C1 and C2 parameters, respectively).

   

 

      

 

        
    

The CVProfilor® DO-2020 provides a patient’s arterial
elasticity indices which can be used in the assessment for
underlying vascular disease.
     

Employing prototype Systems of the CVProfilor® DO-2020, clinical investigators have demonstrated an age-related loss of elasticity of both the large and small arteries as well as a correlation between hardening of the arteries and vascular disease. This clinical research, conducted during the last decade and described in more than 300 scientific abstracts and articles published in peer-reviewed medical journals, suggests that "premature stiffening" of a patient’s arteries is a clinically sensitive marker for the early onset of cardiovascular disease.

Clinical studies have shown that patients with hypertension, heart failure, coronary artery disease and diabetes exhibit a loss of arterial elasticity. Even a slight reduction in arterial elasticity can be measured by the CVProfilor® DO-2020 System, and the early detection of such reductions appear to precede the overt signs and symptoms of cardiovascular disease.

It is generally recognized by medical experts that healthy arteries are elastic and flexible, and that hardening or stiffening of arteries is associated with old age, poor health and cardiovascular disease. Cardiovascular disease is the leading cause of death worldwide. The American Heart Association estimates that nearly 73 million American adults have high blood pressure and that 36% of all deaths in the United States (as of 2004) can attribute cardiovascular disease as the underlying cause of death. Cardiovascular disease is the primary cause of more than one and a half million heart attacks and strokes annually. Every 24 hours, more than 2,400 Americans die of disease involving the cardiovascular system – an average of one death every 37 seconds!

   

   

The CVProfilor® MD-3000: A CE Marked system available to physicians outside of the United States. 

The CVProfilor® MD-3000 functions similar to the
U.S. CVProfilor® DO-2020.

   

The CVProfilor® MD-3000 model is not cleared by the Food and Drug Administration (FDA) for marketing in the United States (please refer to the CVProfilor® DO-2020 for sale in the United States).

The CVProfilor MD-3000 provides a sensitive and specific guide to the presence of blood vessel disease. The ability to detect reduced arterial elasticity is a significant medical advance. The MD-3000 provides physicians with a simple non-invasive technique for:

  • Screening patients with risk factors for the early detection of atherosclerotic disease.

  • Clinically evaluating the efficacy of prescribed lifestyle modifications and/or medications.

  • Monitoring the treatment of patients with hypertension and other cardiovascular diseases.

  • Identifying patients with abnormal arterial-wall function indicative of endothelial dysfunction, and targeting those patients in need of aggressive medical intervention.

   

      

The HDI/PulseWave CR-2000: An easy-to-use, non-invasive System designed for research purposes.
       

The HDI/PulseWave™ CR-2000 is a plug-and-play system that requires no additional accessories.
   

The HDI/PulseWave CR-2000 Research CardioVascular Profiling System provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in a variety of areas including:

  • Pharmaceutical Studies

  • Hypertension

  • Diabetes

  • Smoking

  • Hormone Replacement Therapy (HRT)

  • Hyperlipidemia

  • Diet and Exercise

  • Renal Failure

  • Endothelial Function

By analyzing non-invasively derived blood pressure waveform data obtained through HDI’s proprietary Arterial PulseWave™ Sensor, the CR-2000 provides information that correlates with 15 cardiovascular parameters:

Blood Pressure Waveform
Systolic Blood Pressure
Diastolic Blood Pressure
Mean Arterial Blood Pressure
Pulse Pressure
Pulse Rate
Estimated Cardiac Ejection Time
Estimated Stroke Volume
Estimated Stroke Volume Index
Estimated Cardiac Output
Estimated Cardiac Index
Large Artery Elasticity Index

    (Capacitive Arterial Compliance)
Small Artery Elasticity Index
    (Oscillatory/Reflective Arterial Compliance)
Systemic Vascular Resistance
Total Vascular Impedance

NOTE: In the United States, the HDI/PulseWave CR-2000 Research CardioVascular Profiling System is for research purposes only. 

The HDI/PulseWave™ Research System has a medical device CE Mark which allows it to be marketed in the European Union. The CR-2000 Research System is available in the following languages: English, German, Italian and Spanish.

   

Back to Top

 

 

 

    

   

    

    

Review a
Sample Report 
produced by the CVProfilor® DO-2020 System.

Review the 
CVProfilor® DO-2020 System
Brochure.

   

   

   

   

   

  

  

  

   

   

   

   

   

  

   

  

   

   

   

  

Review a
Sample Report 
produced by the CVProfilor® MD-3000 System.

Review the 
CVProfilor® MD-3000 System
Brochure.

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Review a 
Sample Report 
produced by the HDI/PulseWave
CR-2000 System.

Review the HDI/PulseWave
CR-2000 System
Brochure.

 

 

 

   

   

 

   

 

 

 

     

Copyright © 2009 Hypertension Diagnostics, Inc
To learn more about HDI, email infoteam@hdii.com 
Last revised Wednesday February 11, 2009